Tandem Payables Turnover vs Capex To Depreciation Analysis

TNDM Stock

USD 35.15 2.38 6.34%

Tandem Diabetes financial indicator trend analysis is much more than just breaking down Tandem Diabetes Care prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tandem Diabetes Care is a good investment. Please check the relationship between Tandem Diabetes Payables Turnover and its Capex To Depreciation accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tandem Diabetes Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Payables Turnover vs Capex To Depreciation

Payables Turnover vs Capex To Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tandem Diabetes Care Payables Turnover account and Capex To Depreciation. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Tandem Diabetes' Payables Turnover and Capex To Depreciation is -0.19. Overlapping area represents the amount of variation of Payables Turnover that can explain the historical movement of Capex To Depreciation in the same time period over historical financial statements of Tandem Diabetes Care, assuming nothing else is changed. The correlation between historical values of Tandem Diabetes' Payables Turnover and Capex To Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Payables Turnover of Tandem Diabetes Care are associated (or correlated) with its Capex To Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Depreciation has no effect on the direction of Payables Turnover i.e., Tandem Diabetes' Payables Turnover and Capex To Depreciation go up and down completely randomly.

Correlation Coefficient

-0.19

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Most indicators from Tandem Diabetes' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tandem Diabetes Care current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tandem Diabetes Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

At this time, Tandem Diabetes' Selling General Administrative is very stable compared to the past year. As of the 18th of January 2025, Tax Provision is likely to grow to about 2.8 M, while Enterprise Value Over EBITDA is likely to drop (14.12).

	2023	2024	2025 (projected)
Interest Expense	9.9M	11.4M	6.0M
Depreciation And Amortization	15.7M	18.1M	19.0M

Interest Expense Depreciation And Amortization

Tandem Diabetes fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets
Total Assets		0.97	0.94	0.96	0.94	0.99	0.96	0.93	-0.87	0.87	0.6	0.95	0.82	0.69	0.98	0.99	0.17	0.91	0.98	0.95	0.93	0.92	0.95	0.97	0.92	1.0
Short Long Term Debt Total	0.97		0.87	0.95	0.85	0.96	0.97	0.98	-0.83	0.89	0.52	0.97	0.9	0.66	0.92	0.95	0.09	0.82	0.93	0.98	0.96	0.91	0.9	0.99	0.95	0.96
Other Current Liab	0.94	0.87		0.97	0.89	0.96	0.89	0.86	-0.9	0.81	0.43	0.89	0.79	0.63	0.9	0.95	0.16	0.97	0.92	0.85	0.91	0.91	0.95	0.9	0.87	0.93
Total Current Liabilities	0.96	0.95	0.97		0.86	0.97	0.97	0.94	-0.9	0.91	0.45	0.97	0.9	0.6	0.9	0.97	0.06	0.93	0.91	0.93	0.98	0.92	0.96	0.96	0.96	0.95
Total Stockholder Equity	0.94	0.85	0.89	0.86		0.91	0.83	0.76	-0.85	0.76	0.72	0.81	0.62	0.69	0.97	0.94	0.29	0.92	0.95	0.79	0.79	0.84	0.93	0.82	0.75	0.96
Other Liab	0.99	0.96	0.96	0.97	0.91		0.94	0.93	-0.91	0.88	0.52	0.94	0.83	0.71	0.95	0.99	0.17	0.92	0.97	0.94	0.94	0.93	0.96	0.96	0.91	0.98
Property Plant And Equipment Net	0.96	0.97	0.89	0.97	0.83	0.94		0.94	-0.84	0.92	0.53	1.0	0.92	0.58	0.88	0.93	0.02	0.84	0.88	0.96	0.98	0.85	0.91	0.98	0.99	0.93
Net Debt	0.93	0.98	0.86	0.94	0.76	0.93	0.94		-0.8	0.86	0.32	0.95	0.93	0.63	0.85	0.91	0.04	0.78	0.89	0.98	0.95	0.93	0.86	0.98	0.95	0.9
Retained Earnings	-0.87	-0.83	-0.9	-0.9	-0.85	-0.91	-0.84	-0.8		-0.89	-0.44	-0.84	-0.75	-0.64	-0.82	-0.9	-0.17	-0.92	-0.83	-0.76	-0.86	-0.83	-0.96	-0.82	-0.82	-0.86
Accounts Payable	0.87	0.89	0.81	0.91	0.76	0.88	0.92	0.86	-0.89		0.45	0.92	0.86	0.47	0.78	0.87	-0.09	0.82	0.78	0.84	0.91	0.77	0.91	0.87	0.91	0.84
Cash	0.6	0.52	0.43	0.45	0.72	0.52	0.53	0.32	-0.44	0.45		0.5	0.25	0.42	0.67	0.55	0.23	0.49	0.55	0.47	0.41	0.34	0.53	0.47	0.42	0.62
Non Current Assets Total	0.95	0.97	0.89	0.97	0.81	0.94	1.0	0.95	-0.84	0.92	0.5		0.94	0.58	0.87	0.93	0.01	0.83	0.87	0.96	0.99	0.87	0.9	0.98	0.99	0.92
Non Currrent Assets Other	0.82	0.9	0.79	0.9	0.62	0.83	0.92	0.93	-0.75	0.86	0.25	0.94		0.45	0.69	0.8	-0.16	0.69	0.73	0.9	0.96	0.82	0.8	0.91	0.97	0.78
Other Assets	0.69	0.66	0.63	0.6	0.69	0.71	0.58	0.63	-0.64	0.47	0.42	0.58	0.45		0.71	0.7	0.76	0.64	0.72	0.64	0.59	0.69	0.67	0.64	0.51	0.7
Cash And Short Term Investments	0.98	0.92	0.9	0.9	0.97	0.95	0.88	0.85	-0.82	0.78	0.67	0.87	0.69	0.71		0.97	0.26	0.9	0.99	0.9	0.84	0.89	0.91	0.91	0.81	0.99
Net Receivables	0.99	0.95	0.95	0.97	0.94	0.99	0.93	0.91	-0.9	0.87	0.55	0.93	0.8	0.7	0.97		0.18	0.94	0.98	0.93	0.92	0.92	0.96	0.95	0.89	0.99
Common Stock Total Equity	0.17	0.09	0.16	0.06	0.29	0.17	0.02	0.04	-0.17	-0.09	0.23	0.01	-0.16	0.76	0.26	0.18		0.23	0.25	0.08	0.03	0.21	0.18	0.07	-0.06	0.21
Common Stock Shares Outstanding	0.91	0.82	0.97	0.93	0.92	0.92	0.84	0.78	-0.92	0.82	0.49	0.83	0.69	0.64	0.9	0.94	0.23		0.91	0.79	0.84	0.85	0.95	0.84	0.8	0.92
Short Term Investments	0.98	0.93	0.92	0.91	0.95	0.97	0.88	0.89	-0.83	0.78	0.55	0.87	0.73	0.72	0.99	0.98	0.25	0.91		0.91	0.86	0.93	0.92	0.92	0.83	0.99
Non Current Liabilities Total	0.95	0.98	0.85	0.93	0.79	0.94	0.96	0.98	-0.76	0.84	0.47	0.96	0.9	0.64	0.9	0.93	0.08	0.79	0.91		0.94	0.9	0.85	0.99	0.94	0.93
Inventory	0.93	0.96	0.91	0.98	0.79	0.94	0.98	0.95	-0.86	0.91	0.41	0.99	0.96	0.59	0.84	0.92	0.03	0.84	0.86	0.94		0.9	0.92	0.96	0.99	0.9
Other Current Assets	0.92	0.91	0.91	0.92	0.84	0.93	0.85	0.93	-0.83	0.77	0.34	0.87	0.82	0.69	0.89	0.92	0.21	0.85	0.93	0.9	0.9		0.9	0.92	0.86	0.92
Other Stockholder Equity	0.95	0.9	0.95	0.96	0.93	0.96	0.91	0.86	-0.96	0.91	0.53	0.9	0.8	0.67	0.91	0.96	0.18	0.95	0.92	0.85	0.92	0.9		0.89	0.88	0.95
Total Liab	0.97	0.99	0.9	0.96	0.82	0.96	0.98	0.98	-0.82	0.87	0.47	0.98	0.91	0.64	0.91	0.95	0.07	0.84	0.92	0.99	0.96	0.92	0.89		0.96	0.95
Property Plant And Equipment Gross	0.92	0.95	0.87	0.96	0.75	0.91	0.99	0.95	-0.82	0.91	0.42	0.99	0.97	0.51	0.81	0.89	-0.06	0.8	0.83	0.94	0.99	0.86	0.88	0.96		0.88
Total Current Assets	1.0	0.96	0.93	0.95	0.96	0.98	0.93	0.9	-0.86	0.84	0.62	0.92	0.78	0.7	0.99	0.99	0.21	0.92	0.99	0.93	0.9	0.92	0.95	0.95	0.88

Click cells to compare fundamentals

Tandem Diabetes Account Relationship Matchups

Tandem Diabetes fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	716.4M	905.1M	1.1B	952.7M	1.1B	1.2B
Short Long Term Debt Total	228.3M	314.7M	419.9M	415.7M	478.0M	501.9M
Other Current Liab	61.1M	75.1M	64.5M	84.6M	97.3M	102.2M
Total Current Liabilities	103.9M	131.9M	165.3M	195.3M	224.5M	235.8M
Total Stockholder Equity	366.3M	433.1M	439.9M	313.6M	360.7M	378.7M
Other Liab	17.7M	27.4M	34.8M	36.1M	41.5M	43.6M
Property Plant And Equipment Net	69.8M	77.9M	179.2M	164.3M	189.0M	198.4M
Net Debt	133.7M	243.5M	247.4M	356.8M	410.3M	430.8M
Retained Earnings	(659.2M)	(634.6M)	(729.2M)	(951.8M)	(856.6M)	(813.8M)
Accounts Payable	17.8M	28.0M	55.7M	49.6M	57.0M	59.9M
Cash	94.6M	71.2M	172.5M	58.9M	67.7M	65.4M
Non Current Assets Total	79.2M	93.6M	202.8M	204.7M	235.4M	247.1M
Non Currrent Assets Other	580K	9.1M	19.0M	37.6M	43.2M	45.4M
Other Assets	708K	29.2M	9.1M	10.7M	12.3M	12.9M
Cash And Short Term Investments	484.9M	623.8M	616.9M	467.9M	538.1M	565.0M
Net Receivables	82.2M	110.7M	114.7M	105.6M	121.4M	127.5M
Common Stock Total Equity	59K	14.3M	64K	65K	74.8K	71.0K
Common Stock Shares Outstanding	61.0M	64.3M	64.1M	65.0M	74.7M	78.5M
Short Term Investments	390.3M	552.6M	444.4M	409.0M	470.4M	493.9M
Liabilities And Stockholders Equity	716.4M	905.1M	1.1B	952.7M	1.1B	1.2B
Non Current Liabilities Total	246.3M	340.2M	447.5M	443.8M	510.3M	535.8M
Inventory	63.7M	68.6M	111.1M	157.9M	181.6M	190.7M
Other Current Assets	12.8M	16.9M	7.2M	16.6M	19.1M	20.0M
Other Stockholder Equity	1.0B	1.1B	1.2B	1.3B	1.5B	1.5B
Total Liab	350.1M	472.0M	612.8M	639.0M	734.9M	771.6M
Property Plant And Equipment Gross	50.0M	77.9M	179.2M	217.1M	249.7M	262.2M
Total Current Assets	637.2M	811.5M	850.0M	748.0M	860.2M	903.2M
Accumulated Other Comprehensive Income	220K	(616K)	(1.8M)	1.4M	1.6M	1.7M
Short Term Debt	18.8M	18.6M	26.2M	17.1M	19.6M	29.9M
Common Stock	62K	64K	65K	66K	75.9K	41.6K
Property Plant Equipment	32.9M	50.0M	50.4M	68.6M	78.8M	82.8M
Current Deferred Revenue	6.1M	10.2M	18.8M	44.0M	50.6M	53.1M
Intangible Assets	8.8M	6.6M	4.6M	2.8M	3.2M	3.5M
Net Tangible Assets	195.0M	366.3M	433.1M	439.9M	505.9M	531.2M
Retained Earnings Total Equity	(624.8M)	(659.2M)	(634.6M)	(729.2M)	(656.3M)	(689.1M)
Capital Surpluse	819.6M	1.0B	1.1B	1.2B	1.3B	776.1M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Tandem Diabetes Care is a strong investment it is important to analyze Tandem Diabetes' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tandem Diabetes' future performance. For an informed investment choice regarding Tandem Stock, refer to the following important reports:

How To Invest In Tandem

Details

Is Tandem Stock a good investment?

Details

What is Tandem Diabetes' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tandem Diabetes Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tandem Diabetes. If investors know Tandem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tandem Diabetes listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.37)

Earnings Share

(1.94)

Revenue Per Share

13.082

Quarterly Revenue Growth

0.314

Return On Assets

(0.1)

The market value of Tandem Diabetes Care is measured differently than its book value, which is the value of Tandem that is recorded on the company's balance sheet. Investors also form their own opinion of Tandem Diabetes' value that differs from its market value or its book value, called intrinsic value, which is Tandem Diabetes' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tandem Diabetes' market value can be influenced by many factors that don't directly affect Tandem Diabetes' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Tandem Diabetes' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tandem Diabetes is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tandem Diabetes' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Tandem Payables Turnover vs Capex To Depreciation Analysis

Payables Turnover vs Capex To Depreciation

Payables Turnover vs Capex To Depreciation Correlation Analysis

Correlation Coefficient

Payables Turnover

Capex To Depreciation

Tandem Diabetes fundamental ratios Correlations

Tandem Diabetes Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Tandem Diabetes fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Other Liab	+ 0.99	Total Assets
Net Receivables	+ 0.99	Total Assets
Total Liab	+ 0.99	Short Long Term Debt Total
Net Receivables	+ 0.99	Other Liab

Other Stockholder Equity	- 0.96	Retained Earnings
Common Stock Shares Outstanding	- 0.92	Retained Earnings
Retained Earnings	- 0.91	Other Liab
Net Receivables	- 0.9	Retained Earnings
Retained Earnings	- 0.9	Total Current Liabilities
Retained Earnings	- 0.9	Other Current Liab